Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Shares, Euro 0.09 nominal value per share
-
Shares outstanding
-
75,893,250
-
Total 13F shares
-
33,204,052
-
Share change
-
+136,599
-
Total reported value
-
$877,941,252
-
Price per share
-
$26.44
-
Number of holders
-
92
-
Value change
-
+$399,199
-
Number of buys
-
51
-
Number of sells
-
40
Institutional Holders of Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) as of Q1 2022
As of 31 Mar 2022,
Merus N.V. - Common Shares, Euro 0.09 nominal value per share (MRUS) was held by
92 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,204,052 shares.
The largest 10 holders included
BVF INC/IL, FEDERATED HERMES, INC., WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, BOXER CAPITAL, LLC, COMMODORE CAPITAL LP, Medicxi Ventures Management (Jersey) Ltd, Aquilo Capital Management, LLC, DRIEHAUS CAPITAL MANAGEMENT LLC, and BIOIMPACT CAPITAL LLC.
This page lists
94
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.